(Q37918316)

25 August 2017

1 reference

title

Advances in the diagnosis, pathogenesis and treatment of CIDP. (English)

1 reference

25 August 2017

0 references

0 references

Marinos C Dalakas

1

1 reference

25 August 2017

Medscape

series ordinal

2

1 reference

25 August 2017

language of work or name

English

0 references

publication date

16 August 2011

1 reference

25 August 2017

published in

Nature Reviews Neurology

1 reference

25 August 2017

volume

7

1 reference

25 August 2017

issue

9

1 reference

25 August 2017

page(s)

507-517

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneurol.2011.121

25 August 2017

exact match

0 references

cites work

Recurrent polyneuropathies and their corticosteroid treatment; with five-year observations of a placebo-controlled case treated with corticotrophin, cortisone, and prednisone

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Chronic inflammatory demyelinating polyneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Chronic relapsing (Dysimmune) polyneuropathy: Pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

What is the best initial treatment for childhood chronic inflammatory demyelinating polyneuropathy: corticosteroids or intravenous immunoglobulin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

"Chronic sensory demyelinating neuropathy": chronic inflammatory demyelinating polyneuropathy presenting as a pure sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Distal acquired demyelinating symmetric neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Incidence and prevalence of CIDP and the association of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Prevalence and incidence rates of chronic inflammatory demyelinating polyneuropathy in the Japanese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Epidemiologic variability of chronic inflammatory demyelinating polyneuropathy with different diagnostic criteria: study of a UK population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Comorbidity between CIDP and diabetes mellitus: only a matter of chance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

The spectrum of chronic inflammatory demyelinating polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculoneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Review of the evolution of electrodiagnostic criteria for chronic inflammatory demyelinating polyradicoloneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Brachial and lumbar plexuses in chronic inflammatory demyelinating polyradiculoneuropathy: MRI assessment including apparent diffusion coefficient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Predicting response to treatment in chronic inflammatory demyelinating polyradiculoneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Enhanced B7 costimulatory molecule expression in inflammatory human sural nerve biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Impairment of circulating CD4+CD25+ regulatory T cells in patients with chronic inflammatory demyelinating polyradiculoneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Circulating subsets and CD4(+)CD25(+) regulatory T cell function in chronic inflammatory demyelinating polyradiculoneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Expression of chemokines in cerebrospinal fluid and serum of patients with chronic inflammatory demyelinating polyneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Gene expression profiling in chronic inflammatory demyelinating polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Differential gene expression in chronic inflammatory demyelinating polyneuropathy (CIDP) skin biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Impaired inhibitory Fcgamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Nodes of ranvier and paranodes in chronic acquired neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

CIDP - the relevance of recent advances in Schwann cell/axonal neurobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Single nucleotide polymorphism of TAG-1 influences IVIg responsiveness of Japanese patients with CIDP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Treatment of chronic inflammatory demyelinating polyneuropathy with pulsed oral steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Electrophysiologic correlations with clinical outcomes in CIDP

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Cyclosporin A in resistant chronic inflammatory demyelinating polyradiculoneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Therapeutic targets in patients with inflammatory myopathies: present approaches and a look to the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Successful autologous stem cell transplantation in a patient with chronic inflammatory demyelinating polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Chronic inflammatory demyelinating polyradiculoneuropathy: a role for haematopoietic stem cell transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

B cells as therapeutic targets in autoimmune neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Invited article: inhibition of B cell functions: implications for neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Rituximab in chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Practical considerations on the use of rituximab in autoimmune neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

An open label clinical trial of complement inhibition in multifocal motor neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Natalizumab treatment in a patient with chronic inflammatory demyelinating polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Advances in chronic inflammatory demyelinating polyneuropathy: disease variants and inflammatory response mediators and modifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Chronic inflammatory demyelinating polyneuropathy sera inhibit axonal growth of mouse dorsal root ganglion neurons by activation of Rho-kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Susceptibility to chronic inflammatory demyelinating polyradiculoneuropathy is associated to polymorphic GA repeat in the SH2D2A gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Chronic relapsing polyneuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Chronic inflammatory demyelinating polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Tremor as a feature of chronic relapsing and dysgammaglobulinemic polyneuropathies. Incidence and management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Childhood chronic inflammatory demyelinating polyneuropathy: clinical course and long-term outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Childhood chronic inflammatory demyelinating neuropathies: clinical course and long-term follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Multifocal demyelinating neuropathy with persistent conduction block

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Pure motor chronic inflammatory demyelinating polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Chronic immune sensory polyradiculopathy: a possibly treatable sensory ataxia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Chronic polyneuropathies in Vest-Agder, Norway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Chronic inflammatory demyelinating polyneuropathy in diabetics: motor conductions are important in the differential diagnosis with diabetic polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Demyelinating neuropathy in diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Chronic inflammatory demyelinating polyradiculoneuropathy associated with multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barré syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Distinguishing acute-onset CIDP from Guillain-Barré syndrome with treatment related fluctuations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor-alpha antagonists

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Current diagnosis of CIDP: the need for biomarkers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

The electrodiagnostic distinctions between chronic familial and acquired demyelinative neuropathies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Chronic inflammatory demyelinating polyneuropathy: immunopathological and ultrastructural study of peripheral nerve biopsy in 42 cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Demyelinating findings in typical and atypical chronic inflammatory demyelinating polyneuropathy: sensitivity and specificity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Validity of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy: a multicentre European study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Chronic inflammatory demyelinating polyneuropathy associated with malignant melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Gangliosides of human melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Molecular mimicry in chronic inflammatory demyelinating polyneuropathy and melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Expression of the co-stimulatory molecule BB-1, the ligands CTLA-4 and CD28 and their mRNAs in chronic inflammatory demyelinating polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Expression of CD28-related costimulatory molecule and its ligand in inflammatory neuropathies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Distribution of Th17 cells and Th1 cells in peripheral blood and cerebrospinal fluid in chronic inflammatory demyelinating polyradiculoneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Expression of endothelial leukocyte adhesion molecule-1 (ELAM-1) in chronic inflammatory demyelinating polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Immunoglobulin and Complement Deposits in Nerves of Patients With Chronic Relapsing Polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Anti-SGPG antibody in CIDP: nosological position of IgM anti-MAG/SGPG antibody-associated neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

CSF "monoclonal" bands in chronic relapsing polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Subcutaneous immunoglobulin infusion: A new therapeutic option in chronic inflammatory demyelinating polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

High-dose cyclophosphamide without stem-cell rescue for refractory CIDP

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

High-dose cyclophosphamide results in long-term disease remission with restoration of a normal quality of life in patients with severe refractory chronic inflammatory demyelinating polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Pulse cyclophosphamide therapy in chronic inflammatory demyelinating polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Mycophenolate mofetil for chronic inflammatory demyelinating polyradiculoneuropathy: An open-label study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Intramuscular interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Rituximab-responsive CIDP

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Potential biomarkers for monitoring therapeutic response in patients with CIDP

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Fas-mediated T-cell apoptosis is impaired in patients with chronic inflammatory demyelinating polyneuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Peripheral neuropathies: Establishing common clinical research standards for CIDP

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.121

Chronic inflammatory polyradiculoneuropathy

31 March 2020

1 reference

12 December 2020

Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force

1 reference

12 December 2020

Passive transfer of demyelination by serum or IgG from chronic inflammatory demyelinating polyneuropathy patients.

1 reference

12 December 2020

Prednisone-responsive hereditary motor and sensory neuropathy

1 reference

12 December 2020

10.1038/NRNEUROL.2011.121

Identifiers

DOI

1 reference

Dimensions Publication ID

25 August 2017

1027776066

0 references

1 reference